| First Author | Scheer N | Year | 2012 |
| Journal | Drug Metab Dispos | Volume | 40 |
| Issue | 11 | Pages | 2212-8 |
| PubMed ID | 22917771 | Mgi Jnum | J:216646 |
| Mgi Id | MGI:5609176 | Doi | 10.1124/dmd.112.047605 |
| Citation | Scheer N, et al. (2012) Generation and characterization of a novel multidrug resistance protein 2 humanized mouse line. Drug Metab Dispos 40(11):2212-8 |
| abstractText | The multidrug resistance protein (MRP) 2 is predominantly expressed in liver, intestine, and kidney, where it plays an important role in the excretion of a range of drugs and their metabolites or endogenous compounds into bile, feces, and urine. Mrp knockout [Mrp2(-/-)] mice have been used recently to study the role of MRP2 in drug disposition. Here, we describe the first generation and initial characterization of a mouse line humanized for MRP2 (huMRP2), which is nulled for the mouse Mrp2 gene and expresses the human transporter in the organs and cell types where MRP2 is normally expressed. Analysis of the mRNA expression for selected cytochrome P450 and transporter genes revealed no major changes in huMRP2 mice compared with wild-type controls. We show that human MRP2 is able to compensate functionally for the loss of the mouse transporter as demonstrated by comparable bilirubin levels in the humanized mice and wild-type controls, in contrast to the hyperbilirubinemia phenotype that is observed in MRP2(-/-) mice. The huMRP2 mouse provides a model to study the role of the human transporter in drug disposition and in assessing the in vivo consequences of inhibiting this transporter by compounds interacting with human MRP2. |
